BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17175377)

  • 1. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma.
    Vauleon E; Auger N; Benouaich-Amiel A; Laigle-Donadey F; Kaloshi G; Lejeune J; Delattre JY; Thillet J; Sanson M
    Cancer Genet Cytogenet; 2007 Jan; 172(1):33-7. PubMed ID: 17175377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between functional EGF+61 polymorphism and glioma risk.
    Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
    Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population.
    Lim YJ; Kim JW; Song JY; Hong MS; Jin SY; Yoon SH; Park HJ; Choe BK; Lee JJ; Yim SV; Hong SI; Baik HH; Ha E; Park YH
    Neurosci Lett; 2005 Feb; 374(3):157-60. PubMed ID: 15663953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma.
    Carpentier C; Laigle-Donadey F; Marie Y; Auger N; Benouaich-Amiel A; Lejeune J; Kaloshi G; Delattre JY; Thillet J; Sanson M
    Neurology; 2006 Sep; 67(5):872-4. PubMed ID: 16885506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.
    Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V
    Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.
    Rodero M; Marie Y; Coudert M; Blondet E; Mokhtari K; Rousseau A; Raoul W; Carpentier C; Sennlaub F; Deterre P; Delattre JY; Debré P; Sanson M; Combadière C
    J Clin Oncol; 2008 Dec; 26(36):5957-64. PubMed ID: 19001328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
    Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
    Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival.
    Almeida LO; Custódio AC; Santos MJ; Almeida JR; Clara CA; Pinto GR; Rey JA; Casartelli C
    Cancer Genet Cytogenet; 2010 Apr; 198(1):15-21. PubMed ID: 20303009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between EGF gene polymorphism and gastric cancer.
    Goto Y; Ando T; Goto H; Hamajima N
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2454-6. PubMed ID: 16214932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
    Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
    Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
    DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
    Teixeira AL; Ribeiro R; Cardoso D; Pinto D; Lobo F; Fraga A; Pina F; Calais-da-Silva F; Medeiros R
    Clin Cancer Res; 2008 Jun; 14(11):3367-71. PubMed ID: 18519765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional Aquaporin 1 -783G/C-polymorphism is associated with survival in patients with glioblastoma multiforme.
    El Hindy N; Rump K; Lambertz N; Zhu Y; Frey UH; Bankfalvi A; Siffert W; Sure U; Peters J; Adamzik M; Sandalcioglu IE
    J Surg Oncol; 2013 Dec; 108(7):492-8. PubMed ID: 24014128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease.
    Bhowmick DA; Zhuang Z; Wait SD; Weil RJ
    Cancer Res; 2004 Feb; 64(4):1220-3. PubMed ID: 14973082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
    Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
    Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.
    Simon M; Ludwig M; Fimmers R; Mahlberg R; Müller-Erkwoh A; Köster G; Schramm J
    Neurosurgery; 2006 Nov; 59(5):1078-85; discussion 1085. PubMed ID: 17016233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene.
    Araújo AP; Ribeiro R; Pereira D; Pinto D; Sousa B; Catarino R; Medeiros R
    Exp Biol Med (Maywood); 2009 Mar; 234(3):241-5. PubMed ID: 19144868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.